Teach me in 10

Teach me in 10: The power of the 6‑base genome for transformative insights into current and future states of disease

Tom Charlesworth, PhD, Director of Market Strategy and Corporate Development, talks about the power of the 6‑base genome for transformative insights into current and future states of disease.
1:00 pm
 to 1:10 pm
 BST, 
7 May 2024
Teach me in 10

Teach me in 10: The power of the 6‑base genome for transformative insights into current and future states of disease

Tom Charlesworth, PhD, Director of Market Strategy and Corporate Development, talks about the power of the 6‑base genome for transformative insights into current and future states of disease.
Originally presented on 7 May 2024.

About the webinar

This Teach Me in 10 will introduce the 6‑base genome (A, T, C, G, 5mC, and 5hmC) delivered by a powerful new technology, duet multiomics solution evoC. The added resolution of duet evoC will enable improved detection of disease associations, identification of novel biomarkers, development of disease classifiers, and monitoring of disease progression.

In this episode, we will discuss:

How the 6-base genome can improve the understanding of tumour biology from liquid biopsy:

  • Methylation states of enhancers in CRC cfDNA samples provide evidence that 5mC and 5hmC track cancer stage with greater precision.
  • 6-letter readouts provide two-dimensional methylation data that shows 5hmC variations that are associated with stage 1 vs healthy​

High-level introduction into how 6‑base genome data can be used to build models that accurately predict gene expression, chromatin accessibility, and enhancer status

Stay up to date

Explore recent biomodal news and the events that we’ll be attending in the near future.

Cambridge Epigenetix is now biomodal